FMS Investing Cash Flow

Fresenius Medical Care AG American Depositary Shares (Each representing 1/2 of an Ordinary Share) · Investing Cash Flow

FMS logo

FMS Investing Cash Flow

Latest reported-€890.56M EUR
FMS TTM Cash from Investing · EUR (-€513.04M → -€890.56M)
High-resolution chart · PNG

FMS investing cash flow history

Trailing twelve months (TTM) · EUR. Each value covers four complete reported quarters.

Fresenius Medical Care AG American Depositary Shares (Each representing 1/2 of an Ordinary Share) Investing Cash Flow — Trailing twelve months (TTM) (EUR)
Period endingInvesting Cash Flow (EUR)
-890,556,165
-761,848,165
-700,610,165
-423,494,000
-589,421,000
-124,813,000
-84,939,000
-62,246,000
6,582,000
-449,317,000
-544,227,000
-672,671,000
-622,359,000
-686,686,000
-734,725,000
-932,570,000
-1,132,038,000
-1,183,491,000
-1,196,228,000
-1,227,786,000
-1,215,196,000
-1,246,662,000
-1,334,942,000
-1,421,386,000
-1,486,603,000
-1,581,869,000
-3,285,987,000
-3,290,737,000
-3,665,850,000
-2,018,918,000
-402,103,000
163,008,000
609,789,000
-1,049,286,000
-1,004,630,000
-1,508,635,146
-1,465,344,768
-1,369,055,729
-1,311,519,285
-1,067,500,113
-1,078,626,017
-1,019,885,594
-915,286,542
-1,560,678,414
-2,018,223,036
-2,164,269,664
-2,212,769,282
-1,626,870,792
-1,183,757,225
-944,758,696
-873,027,957
-743,745,022
-617,721,645
-658,676,478
-1,724,940,594
-2,222,001,399
-2,292,391,371
-2,725,733,203
-1,809,955,227
-1,467,907,851
-1,368,804,337
-1,031,463,782
-845,905,546
-703,106,752
-699,058,375
-511,444,664
-487,192,831
-502,993,934
-570,639,555
-632,803,318
-640,328,994
-642,309,399
-560,874,742
-502,060,080
-532,888,754
-429,216,499
-442,519,129
4,773,853
-3,213,448,152
-3,267,263,831
-3,245,800,696
-3,675,728,446
-356,716,753
-300,520,592
-272,063,087
-249,385,753
-269,155,089
-289,246,303
-295,777,888
-297,171,548
-292,698,515
-213,111,273
-255,122,379
-263,082,625
-267,986,600
-656,524,487
-335,402,952
-389,480,800
-525,698,788
-195,270,368
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.